Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. He received his Bachelor of Arts in Economics and Political Science from Williams College. Ilir received his B.S.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

APRIL 19, 2024

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. In fact, projections for the global spatial computing market are valued at $269.8 In any case, this technology is one to watch—the global computing market is set to grow at a CAGR of 28.8%

Technology 69

Technology Technology Retail Due Diligence 69

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

MARCH 13, 2024

According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Wink Intel

FEBRUARY 23, 2021

We are excited to continue working with leading global financial institutions to further round out our fixed index annuity portfolio,” said American Equity Chief Executive Officer Anant Bhalla. tech and biotech ETFs and two fixed income components. Societe Generale is one of the largest European financial services groups.

Intellectual Property 40

Intellectual Property Banking Biotech Retail 40

Alpha Sense BI

MARCH 28, 2023

Value: To date, GLG serves leading technology, life science, and industrial companies, including 40% of the Fortune 100 and seven of the top 10 global technology companies; leading investment and financial firms; top professional services firms; and hundreds of nonprofits and social entrepreneurs around the world.

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52

Alpha Sense BI

NOVEMBER 9, 2022

A lot of the improvements that I talked about on a macro level, capital efficiency, operations improvements are as important internationally as they are in North America.” – Brian T. M&A IPOs to watch in Pharma and Biotech. Capital deployment and business development were a big focus during the call. JOYY Inc. [YY].

Sales 52

Sales Loss Capital Biotech 52

CIO

MARCH 4, 2025

Meanwhile, annual global investment in deep tech quadrupled from $15B to over $60B in 20162020 , signaling that investors see shorter paths to profit and indicating more technologies funded five or more years ago have now reached commercial readiness. Family businesses also increasingly allocate capital to deep tech innovation.

Technology 442

Technology Technology Biotech Business 442

Alpha Sense BI

MARCH 14, 2025

The venture capital sector is poised for a long-awaited return to dealmaking, fund deployment, and exit opportunities in 2025. Data from the National Venture Capital Association (NVCA) illustrates a massive backlog in VC exits. Deregulation is also expected to prime the IPO and deal environment. January VC funding came in at $3.4

Capital 59

Capital Biotech Startups Finance 59

Alpha Sense BI

FEBRUARY 6, 2025

In 2024, global M&A volume reached $3.4 North America led global M&A activity with 50% of deal volume, followed by EMEA at 25% and APAC at 22%. The tech sector accounted for 19% of global deal volume, followed by healthcare at 10% and finance at 9%. Capital Ones Acquisition of Discover Financial: $35.3

Biotech 59

Biotech Capital Pharmaceutical Finance 59

Happy Market

MAY 9, 2022

We started this company in – I sort of kind of started it I guess in 2007, but we were really starting to raise capital and get the business off the ground in 2008, which was a horrific economic climate. John Dick: Right. [00:36:04].

Management 52

Management Entertainment Market Research Marketing Research 52

Alpha Sense BI

JANUARY 8, 2025

RFK), have clouded 2025 visibility for the healthcare sector and generated a mix of expectations for healthcare systems and providers, health insurers, and biotech/pharma companies. Director with a large managed care organization Biotech and Pharma The Trump administration is expected to bring a relaxation of antitrust enforcement.

Innovation 69

Innovation Biotech Pharmaceutical Benchmarking 69